Navigation Links
Novel Imaging Software Released by Celsense Inc.

Molecular & cellular image manipulation software, Voxel Tracker™ is first-of-its-kind

Pittsburgh, PA (Vocus) March 18, 2010 -- Celsense, Inc. announced today its launch of the first off-the-shelf software for merging scanner images. The software, dubbed Voxel Tracker™, was designed to optimize the use of Celsense’ imaging reagents but will be made available to any researcher wanting to benefit from the ability to merge scanner images.

Voxel Tracker™ is designed to allow researchers to manipulate and quantify molecular imaging data by merging images produced from different imaging scanners.

When used in conjunction with Celsense imaging reagents, Voxel Tracker™ optimizes the utility of imaging data by allowing researchers to quantify cells and/or inflammation in vivo in a specific region of interest. This is accomplished by merging the images in question. For example, merging NMR and MRI images when using the reagent Cell Sense provides researchers with spatial data pertaining to cell location and biodistribution that is otherwise unavailable.

Celsense contracted with Umlaut Software to develop Voxel Tracker™ after its market research demonstrated that existing ad hoc methods to manipulate and quantify molecular imaging data produced less than satisfactory results. The software is powered by Umlaut Software's VoxPort, a platform of software solutions and tools to manage, deliver, and analyze large volumes of imagery and metadata in rigorous production environments. Umlaut will provide ongoing production and technical support to Celsense Inc. and its customers.

A web based version of the Voxel Tracker™ is available by annual subscription and will be accessed by users via the online portal at The workstation version of Voxel Tracker™ will be available later this year.

Celsense, Inc. has three reagents for MRI imaging of cells currently on the market for pre-clinical research and discovery. The company also offers Voxel Tracker workstation software that maximizes the Cell Sense MRI data set. Customers include leading pharmaceutical and biotechnology companies and medical research centers worldwide.

About Voxel Tracker™
Voxel Tracker™ is a powerful software product that optimizes the use of Celsense imaging reagents. The Voxel Tracker™ software program enables rapid visualization and quantification of MRI-labeled cells. The image processing toolbox fuses and visualizes three-dimensional 1H and 19F images. Powerful, built-in, computational tools enable cell or inflammation quantification in regions of interest, thus enriching the utility of in vivo data. Voxel Tracker™ is currently offered via convenient web-based access. A workstation version of Voxel Tracker™ will be available later this year. See for more information.

About Celsense, Inc.
Celsense, Inc. offers products that enable the non-invasive imaging of cells in vivo using MRI. The mission of the company is to be the standard for cellular imaging in human health.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Going for gold with a novel interventional radiology treatment for pancreatic cancer
2. Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136
3. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
4. Melanoma transcriptome reveals novel genomic alterations not seen before
5. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
6. Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner
7. Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy
8. Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer
9. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
10. For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
11. For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
Post Your Comments:
Related Image:
Novel Imaging Software Released by Celsense Inc.
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography ... generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter phase ...
(Date:10/7/2017)... Oct. 6, 2017  The 2017 Nobel Prize ... scientists, Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to ... structural biology community. The winners worked with systems ... routinely produce highly resolved, three-dimensional images of protein ...
Breaking Biology Technology:
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
Breaking Biology News(10 mins):